Orion’s collaboration partner Bayer announced the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the oral androgen...
miR Scientific, LLC announces the miR Sentinel Prostate Cancer Test is now commercially available in the United States, Puerto Rico and select international markets....
ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the first patient dosed in...
